Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome


Por: Heitsch, L, Ibanez, L, Carrera, C, Binkley, MM, Strbian, D, Tatlisumak, T, Bustamante, A, Ribo, M, Molina, C, Davalos, A, Lopez-Cancio, E, Munoz-Narbona, L, Soriano-Tarraga, C, Giralt-Steinhauer, E, Obach, V, Slowik, A, Pera, J, Lapicka-Bodzioch, K, Derbisz, J, Sobrino, T, Castillo, J, Campos, F, Rodriguez-Castro, E, Arias-Rivas, S, Segura, T, Serrano-Heras, G, Vives-Bauza, C, Diaz-Navarro, R, Tur, S, Jimenez, C, Marti-Fabregas, J, Delgado-Mederos, R, Arenillas, J, Krupinski, J, Cullell, N, Torres-Aguila, NP, Muino, E, Carcel-Marquez, J, Moniche, F, Cabezas, JA, Ford, AL, Dhar, R, Roquer, J, Khatri, P, Jimenez-Conde, J, Fernandez-Cadenas, I, Montaner, J, Rosand, J, Cruchaga, C, Lee, JM

Publicada: 1 ene 2021
Resumen:
Background and Purpose: Large-scale observational studies of acute ischemic stroke (AIS) promise to reveal mechanisms underlying cerebral ischemia. However, meaningful quantitative phenotypes attainable in large patient populations are needed. We characterize a dynamic metric of AIS instability, defined by change in National Institutes of Health Stroke Scale score (NIHSS) from baseline to 24 hours baseline to 24 hours (NIHSSbaseline - NIHSS24hours = Delta NIHSS6-24h), to examine its relevance to AIS mechanisms and long-term outcomes. Methods: Patients with NIHSS prospectively recorded within 6 hours after onset and then 24 hours later were enrolled in the GENISIS study (Genetics of Early Neurological Instability After Ischemic Stroke). Stepwise linear regression determined variables that independently influenced Delta NIHSS6-24h. In a subcohort of tPA (alteplase)-treated patients with large vessel occlusion, the influence of early sustained recanalization and hemorrhagic transformation on Delta NIHSS6-24h was examined. Finally, the association of Delta NIHSS6-24h with 90-day favorable outcomes (modified Rankin Scale score 0-2) was assessed. Independent analysis was performed using data from the 2 NINDS-tPA stroke trials (National Institute of Neurological Disorders and Stroke rt-PA). Results: For 2555 patients with AIS, median baseline NIHSS was 9 (interquartile range, 4-16), and median Delta NIHSS6-24h was 2 (interquartile range, 0-5). In a multivariable model, baseline NIHSS, tPA-treatment, age, glucose, site, and systolic blood pressure independently predicted Delta NIHSS6-24h (R-2=0.15). In the large vessel occlusion subcohort, early sustained recanalization and hemorrhagic transformation increased the explained variance (R-2=0.27), but much of the variance remained unexplained. Delta NIHSS6-24h had a significant and independent association with 90-day favorable outcome. For the subjects in the 2 NINDS-tPA trials, Delta NIHSS3-24h was similarly associated with 90-day outcomes. Conclusions: The dynamic phenotype, Delta NIHSS6-24h, captures both explained and unexplained mechanisms involved in AIS and is significantly and independently associated with long-term outcomes. Thus, Delta NIHSS6-24h promises to be an easily obtainable and meaningful quantitative phenotype for large-scale genomic studies of AIS.

Filiaciones:
Heitsch, L:
 Washington Univ, Div Emergency Med, Sch Med, St Louis, MO 63110 USA

 Washington Univ, Dept Neurol, Sch Med, St Louis, MO 63110 USA

Ibanez, L:
 Washington Univ, Dept Psychiat, Sch Med, St Louis, MO 63110 USA

Carrera, C:
 Univ Autonoma Barcelona, Vall dHebron Inst Res VHIR, Neurovasc Res Lab, Barcelona, Spain

 Univ Autonoma Barcelona, Vall dHebron Inst Res VHIR, Neurovasc Unit, Barcelona, Spain

 Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Neurol, Barcelona, Spain

Binkley, MM:
 Washington Univ, Dept Neurol, Sch Med, St Louis, MO 63110 USA

Strbian, D:
 Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland

Tatlisumak, T:
 Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland

 Univ Gothenburg, Dept Clin Neurosci, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden

 Sahlgrens Univ Hosp, Dept Neurol, Gothenburg, Sweden

Bustamante, A:
 Univ Autonoma Barcelona, Vall dHebron Inst Res VHIR, Neurovasc Res Lab, Barcelona, Spain

 Univ Autonoma Barcelona, Vall dHebron Inst Res VHIR, Neurovasc Unit, Barcelona, Spain

 Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Neurol, Barcelona, Spain

Ribo, M:
 Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Neurol, Barcelona, Spain

Molina, C:
 Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Neurol, Barcelona, Spain

Davalos, A:
 Hosp Badalona Germans Trias & Pujol, Dept Neurol, Badalona, Spain

Lopez-Cancio, E:
 Hosp Univ Cent Asturias HUCA, Dept Neurol, Oviedo, Spain

Munoz-Narbona, L:
 Inst Hosp Mar Invest Med IMIM, Barcelona, Spain

Soriano-Tarraga, C:
 Inst Hosp Mar Invest Med IMIM, Barcelona, Spain

Giralt-Steinhauer, E:
 Inst Hosp Mar Invest Med IMIM, Barcelona, Spain

 Hosp Mar, Dept Neurol, Barcelona, Spain

Obach, V:
 Univ Barcelona, Hosp Clin, Dept Neurosci, Barcelona, Spain

 August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain

Slowik, A:
 Jagiellonian Univ Med Coll, Dept Neurol, Krakow, Poland

Pera, J:
 Jagiellonian Univ Med Coll, Dept Neurol, Krakow, Poland

Lapicka-Bodzioch, K:
 Jagiellonian Univ Med Coll, Dept Neurogenet, Krakow, Poland

Derbisz, J:
 Jagiellonian Univ Med Coll, Dept Neurol, Krakow, Poland

Sobrino, T:
 Univ Santiago de Compostela, Hosp Clin Univ, Hlth Res Inst Santiago de Compostela, Clin Neurosci Res Lab, Santiago De Compostela, Spain

 Hosp Univ Albacete, Dept Neurol, Albacete, Spain

Castillo, J:
 Univ Santiago de Compostela, Hosp Clin Univ, Hlth Res Inst Santiago de Compostela, Clin Neurosci Res Lab, Santiago De Compostela, Spain

Campos, F:
 Univ Santiago de Compostela, Hosp Clin Univ, Hlth Res Inst Santiago de Compostela, Clin Neurosci Res Lab, Santiago De Compostela, Spain

Rodriguez-Castro, E:
 Univ Santiago de Compostela, Hosp Clin Univ, Hlth Res Inst Santiago de Compostela, Clin Neurosci Res Lab, Santiago De Compostela, Spain

Arias-Rivas, S:
 Univ Santiago de Compostela, Hosp Clin Univ, Hlth Res Inst Santiago de Compostela, Clin Neurosci Res Lab, Santiago De Compostela, Spain

Segura, T:
 Univ Santiago de Compostela, Hosp Clin Univ, Hlth Res Inst Santiago de Compostela, Clin Neurosci Res Lab, Santiago De Compostela, Spain

 Hosp Univ Albacete, Dept Neurol, Albacete, Spain

Serrano-Heras, G:
 Hosp Univ Albacete, Dept Neurol, Albacete, Spain

Vives-Bauza, C:
 IdISBa, Dept Neurol, Son Espases Univ Hosp, Palma De Mallorca, Spain

Diaz-Navarro, R:
 IdISBa, Dept Neurol, Son Espases Univ Hosp, Palma De Mallorca, Spain

Tur, S:
 IdISBa, Dept Neurol, Son Espases Univ Hosp, Palma De Mallorca, Spain

Jimenez, C:
 IdISBa, Dept Neurol, Son Espases Univ Hosp, Palma De Mallorca, Spain

Marti-Fabregas, J:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona, Spain

Delgado-Mederos, R:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona, Spain

Arenillas, J:
 Hosp Clin Univ Valladolid, Dept Neurol, Valladolid, Spain

Krupinski, J:
 Hosp Mutua Terrassa, Dept Neurol, Barcelona, Spain

 Manchester Met Univ, Ctr Biosci, Sch Life Sci, Manchester, Lancs, England

Cullell, N:
 St Pau Hosp, Fundacio Docencia & Recerca Mutua Terrassa, Stroke Pharmacogen & Genet, Barcelona, Spain

 St Pau Hosp, St Pau Inst Res, Stroke Pharmacogen & Genet, Barcelona, Spain

Torres-Aguila, NP:
 St Pau Hosp, St Pau Inst Res, Stroke Pharmacogen & Genet, Barcelona, Spain

Muino, E:
 St Pau Hosp, Fundacio Docencia & Recerca Mutua Terrassa, Stroke Pharmacogen & Genet, Barcelona, Spain

 St Pau Hosp, St Pau Inst Res, Stroke Pharmacogen & Genet, Barcelona, Spain

Carcel-Marquez, J:
 St Pau Hosp, Fundacio Docencia & Recerca Mutua Terrassa, Stroke Pharmacogen & Genet, Barcelona, Spain

 St Pau Hosp, St Pau Inst Res, Stroke Pharmacogen & Genet, Barcelona, Spain

Moniche, F:
 Hosp Univ Virgen del Rocio, Dept Neurol, Seville, Spain

Cabezas, JA:
 Hosp Univ Virgen del Rocio, Dept Neurol, Seville, Spain

Ford, AL:
 Washington Univ, Dept Neurol, Sch Med, St Louis, MO 63110 USA

Dhar, R:
 Washington Univ, Dept Neurol, Sch Med, St Louis, MO 63110 USA

Roquer, J:
 Inst Hosp Mar Invest Med IMIM, Barcelona, Spain

 Hosp Mar, Dept Neurol, Barcelona, Spain

Khatri, P:
 Univ Cincinnati, Dept Neurol, Cincinnati, OH 45221 USA

Jimenez-Conde, J:
 Inst Hosp Mar Invest Med IMIM, Barcelona, Spain

 Hosp Mar, Dept Neurol, Barcelona, Spain

Fernandez-Cadenas, I:
 Univ Autonoma Barcelona, Vall dHebron Inst Res VHIR, Neurovasc Res Lab, Barcelona, Spain

 Univ Autonoma Barcelona, Vall dHebron Inst Res VHIR, Neurovasc Unit, Barcelona, Spain

 Hosp Mutua Terrassa, Dept Neurol, Barcelona, Spain

 St Pau Hosp, Fundacio Docencia & Recerca Mutua Terrassa, Stroke Pharmacogen & Genet, Barcelona, Spain

Montaner, J:
 Univ Autonoma Barcelona, Vall dHebron Inst Res VHIR, Neurovasc Res Lab, Barcelona, Spain

 Univ Autonoma Barcelona, Vall dHebron Inst Res VHIR, Neurovasc Unit, Barcelona, Spain

 Univ Seville, Inst Biomed Seville, IBiS Hosp Univ Virgen del Rocio, CSIC, Seville, Spain

 Hosp Univ Virgen Macarena, Dept Neurol, Seville, Spain

Rosand, J:
 Harvard Med Sch, Div Neurocrit Care & Emergency Neurol, Massachusetts Gen Hosp, Henry & Alison Ctr Brain Hlth,Ctr Genom Med, Boston, MA 02115 USA

Cruchaga, C:
 Washington Univ, Dept Psychiat, Sch Med, St Louis, MO 63110 USA

Lee, JM:
 Washington Univ, Dept Neurol, Sch Med, St Louis, MO 63110 USA
ISSN: 00392499





STROKE
Editorial
LIPPINCOTT WILLIAMS & WILKINS, TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 52 Número: 1
Páginas: 132-141
WOS Id: 000603081900046
ID de PubMed: 33317415
imagen Bronze

MÉTRICAS